Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | SLC18A3 | Q16572 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7377837 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRALOX5SLC18A3LMNA | |
| SCHEMBL5708868 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRALOX5SLC18A3LMNA | |
| SCHEMBL31382808 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRALOX5SLC18A3LMNA | |
| SCHEMBL9035146 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRALOX5SLC18A3LMNA | |
| SCHEMBL527305 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRALOX5SLC18A3LMNA | |
| SCHEMBL3372644 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRALOX5SLC18A3LMNA | |
| SCHEMBL17951347 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRALOX5SLC18A3LMNA | |
| Methane SCHEMBL22471696 | 0.97 | ALDH1A1 (0.44) | ALDH1A1TSHRALOX5SLC18A3 | |
| Hydrochloric Acid SCHEMBL27683979 | 0.97 | ALDH1A1 (0.44) | ALDH1A1TSHRALOX5SLC18A3 | |
| SCHEMBL9909854 | 0.94 | ALDH1A1 (0.39) | ALDH1A1TSHRALOX5LMNACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 906 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250344991-A1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-11-13 | — | — | US | claimed |
| EP-3648613-B1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-09-24 | — | — | EP | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2024-02-15 | — | — | US | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| US-20230172525-A1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | THE ROCKEFELLER UNIVERSITY | 2023-06-08 | — | — | US | claimed |
| CN-112552627-B | Polymeric film and laminate comprising same | 长春石油化学股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| EP-4096618-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2022-12-07 | — | — | EP | claimed |
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| EP-1300487-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Co. L.L.C. (US) | 2003-04-09 | — | — | EP | claimed |
| EP-1294792-A1 | ORGANOLEPTICALLY ACTIVE ALCOHOLS BONDED TO BIODEGRADABLE POLYESTER | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-26 | — | — | EP | claimed |
| EP-1287053-A1 | URETHANE BASED ON ORGANOLEPTICALLY ACTIVE AROMATIC ALCOHOLS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-05 | — | — | EP | claimed |
| US-6500797-B1 | Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones | THE PROCTER & GAMBLE COMPANY | 2002-12-31 | — | — | US | claimed |
| WO-2002055648-A1 | GELS FOR THE TARGETED RELEASE OF ODORIFEROUS SUBSTANCES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-07-18 | — | — | WO | claimed |
| EP-0918835-B1 | RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE PRECURSORS | PROCTER & GAMBLE (US) | 2002-01-16 | — | — | EP | claimed |
| WO-2001094442-A1 | ORGANOLEPTICALLY ACTIVE ALCOHOLS BONDED TO BIODEGRADABLE POLYESTER | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-13 | — | — | WO | claimed |
| WO-2001094438-A1 | URETHANE BASED ON ORGANOLEPTICALLY ACTIVE AROMATIC ALCOHOLS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-13 | — | — | WO | claimed |
| WO-1997031061-A1 | RESIN COMPOSITION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1997-08-28 | — | — | WO | claimed |
| US-4937176-A | Method of manufacturing a semiconductor device, in which a negative image is formed on a semiconductor substrate in a positive photolacquer | U.S. PHILIPS CORPORATION (US) | 1990-06-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | OR10J3, OR51E2, MAL2 | ALDH1A1 27/4885TSHR 4469/4885ALOX5 426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.